Colorado biotech shares soars after patent issued in Europe
Shares in Arca Biopharma Inc. were soaring in early Thursday trading after the biotech reported that one of its treatments for cardiovascular disease has been issued a patent in Europe.
The Westminster biotech reported that the European patent was validated in: Denmark, France, Germany, Ireland, Italy, Netherlands, Spain, Sweden, Switzerland and the United Kingdom.
Shares in Arca Biopharma (Nasdaq: ABIO) were up more than 30 percent in early Thursday trading, rising 37 cents to $1.55.
The company…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Ben Miller Source Type: news
More News: Biotechnology | Cardiology | Cardiovascular | Denmark Health | France Health | Germany Health | Health Management | Heart | Ireland Health | Italy Health | Netherlands Health | Pharmaceuticals | Spain Health | Sweden Health | Switzerland Health | UK Health